There are 2 papers on MIR-206 in aging research: none in people yet, 1 in animals, 1 review.
At a glance
The findings reach mice, none yet in people. 1 lab in 1 country.
Mice: a single group. Cells, worms or flies and humans: nothing yet.
- 1 lab in 1 country
- Animals1
Effects
2Amyotrophic lateral sclerosis
downin reviews1
1 study
Amyotrophic lateral sclerosis
downin reviews1
MIR-206 protects against amyotrophic lateral sclerosis in ALS.
“showing miR-206 as harmful in Alzheimer's, stroke, and depression, but potentially protective in amyotrophic lateral sclerosis (ALS).”
Reviewin ALS
Neuroscience and biobehavioral reviews
BDNF
downin reviews1
1 study
BDNF
downin reviews1
MIR-206 inhibits BDNF in CNS.
“where it targets brain-derived neurotrophic factor (BDNF), reducing neuroplasticity”
Reviewin CNS
Neuroscience and biobehavioral reviews
Associations
1PPARγ
upin rats1
1 study
PPARγ
upin rats1
MIR-206 is associated with PPARγ in the moderate-intensity resistance training group (r = 0.908, p = 0.012).
“myomiR-206 and peroxisome proliferator-activated receptor gamma (PPARγ) (r = 0.908; p = 0.012) in the MIRT group”
Animalsin the moderate-intensity resistance training groupmales
Experimental gerontology
Latest
1 paper in 12 monthsNeuroscience and Biobehavioral Reviews
miRNA-206 in muscle and central nervous system crosstalk during exercise: A double-edged sword with therapeutic potential
ReviewMuscle